The FDA has updated the emergency use authorization (EUA) for Pfizer Inc’s (NYSE:PFE) Paxlovid, impacting its distribution and use in treating mild-to-moderate COVID-19. In December 2021, the FDA ...

Older adult male sitting in his home living room looking at some medication bottles and a laptop on a small, low coffee table in front of him Paxlovid has become a pivotal treatment for COVID-19, ...

Some people like surprises, but I don’t know anyone who likes a surprise bill. It can sometimes be difficult to anticipate costs in health care and to know what questions to ask about coverage. Who is ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. As California gears up for a winter ...

Two government-run efforts to distribute free COVID-19 tests and to offer free courses of Pfizer's Paxlovid antiviral are set to end Friday, as trends of the virus have largely slowed. The ...

As California gears up for a winter of respiratory illnesses, health officials and providers often reference one encouraging factor — the greater availability of COVID-19 treatments and antivirals ...